GlassScriptPhysician profile
Jeffrey M Lafond
NPI 1245243500
$1,890.57
in general payments reported to CMS, 2019-2025
33 companies · $504 in 2025
The $504 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $253 · 2020: $114 · 2021: $172 · 2022: $153 · 2023: $185 · 2024: $509 · 2025: $504.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,198.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $327.75 | 2020-2025 | Stravix, Grafix Pl, Oasis |
| Tela Bio, INC. | $212.28 | 2021-2025 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Davol INC. | $150.08 | 2020-2025 | Phasix Mesh |
| Allergan, INC. | $132.46 | 2019 | |
| Lemaitre Vascular, INC. | $94.60 | 2022-2025 | Artegraft Vascular Graft |
| Kci USA, INC. | $93.18 | 2020-2023 | V.A.C. Veraflo, Prevena, V.A.C. Dermatac |
| Medtronic, INC. | $89.70 | 2024-2025 | Emprint, Plasmablade(Tm) |
| Ferring Pharmaceuticals INC. | $66.77 | 2019-2023 | Rebyota |
| Polynovo North America LLC | $59.84 | 2024 | Novosorb Btm |
| Ethicon US, LLC | $54.84 | 2024 | Enseal X1, Surgiflo Hemostatic Matrix, Surgicel Nu-Knit |
| Merck Sharp & Dohme LLC | $52.33 | 2022-2025 | Lynparza, Keytruda |
| Angiodynamics, INC. | $45.83 | 2024-2025 | Nanoknife |
| Sanara Medtech INC. | $43.27 | 2024-2025 | Celleraterx, Celleraterx |
| Abbvie INC. | $40.60 | 2020-2025 | |
| Intuitive Surgical, INC. | $39.75 | 2019 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $36.40 | 2022-2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Acera Surgical, INC. | $35.35 | 2023-2024 | Restrata Wound Matrix |
| Histosonics, INC. | $34.68 | 2024 | |
| Integra Lifesciences Corporation | $29.97 | 2025 | Integra, Omnigraft, Integra Dermal Regeneration Template |
| Vertex Pharmaceuticals Incorporated | $26.75 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $25.57 | 2025 | Exparel |
| Abbott Laboratories | $23.32 | 2019 | |
| Aroa Biosurgery Incorporated | $19.46 | 2025 | |
| Innocoll Pharmaceuticals Limited | $18.67 | 2021 | |
| Access Pro Medical, LLC | $18.01 | 2023 | Matriderm |
| Acell, INC. | $17.84 | 2019 | |
| Distalmotion US | $17.61 | 2025 | Dexter L6 Robot |
| W. L. Gore & Associates, INC. | $14.95 | 2022 | |
| Medtronic USA, INC. | $14.36 | 2019 | |
| Solventum Corporation | $14.17 | 2025 | Activ.A.C. |
| Lexington Medical, INC. | $13.77 | 2025 | Aeon Endostapler & Echelon Flex Powered Stapler |
| Mimedx Group, INC. | $13.52 | 2024 | |
| Covidien LP | $12.89 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Lafond listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.